| 1. |
- Eron, Joseph J., et al.
(author)
-
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
- 2019
-
In: Antiviral Research. - : Elsevier BV. - 0166-3542 .- 1872-9096. ; 170
-
Journal article (peer-reviewed)abstract
- © 2019 The Authors Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed viral load [VL] ≥50 copies/mL) and VL < 50 copies/mL (virologic suppression) and ≥50 copies/mL (VF) (FDA-snapshot analysis). Of 1141 randomized patients, 1080 continued in the extension phase. Few patients had PDVR (D/C/F/TAF: 3.1%, 24/763 cumulative through week 96; late-switch: 2.3%, 8/352 week 52–96). Week 96 virologic suppression was 90.7% (692/763) (D/C/F/TAF) and 93.8% (330/352) (late-switch). VF was 1.2% and 1.7%, respectively. No darunavir, primary PI, tenofovir or emtricitabine resistance-associated mutations were observed post-baseline. No patients discontinued for efficacy-related reasons. Few discontinued due to adverse events (2% D/C/F/TAF arm). Improved renal and bone parameters were maintained in the D/C/F/TAF arm and observed in the late-switch arm, with small increases in total cholesterol/high-density-lipoprotein-cholesterol ratio. A study limitation was the lack of a control arm in the week 96 analysis. Through 96 weeks, D/C/F/TAF resulted in low PDVR rates, high virologic suppression rates, very few VFs, and no resistance development. Late-switch results were consistent with D/C/F/TAF week 48 results. EMERALD week 96 results confirm the efficacy, high genetic barrier to resistance and safety benefits of D/C/F/TAF.
|
|
| 2. |
- Lögdberg, Sara, et al.
(author)
-
Effect of water on the space-time yield of different supported cobalt catalysts during Fischer-Tropsch synthesis
- 2011
-
In: Applied Catalysis A. - : Elsevier BV. - 0926-860X .- 1873-3875. ; 393:1-2, s. 109-121
-
Journal article (peer-reviewed)abstract
- The effect of partial pressure of water on the Fischer-Tropsch (FT) rate of six cobalt-based catalysts supported on three different carrier materials (gamma-Al2O3, alpha-Al2O3, TiO2) with varying Co particle sizes was investigated in a fixed-bed reactor by changing space velocity and by external water vapour addition. A typical catalyst pellet size (<100 mu m) for industrial slurry-bed FT reactors was used. Water was found to have a positive kinetic effect, at least up to moderate amounts, on the FT rate of all catalysts in the present study, including the gamma-Al2O3-supported catalyst with pores smaller than similar to 10 nm. The reason for the apparent negative effect on the space-time yield at a direct exposure of Co supported on narrowpore gamma-Al2O3 to high partial pressures of water is due to a rapid and extensive deactivation. This could be ascribed to formation of hard-to-reduce oxidized cobalt species. The choice of support material was found to have a major effect on the response to changes in partial pressure of water, both with respect to deactivation behaviour and kinetics. However, there is a minor Co-particle size effect on the magnitude of the kinetic effect of water, larger Co particles showing a more positive response. Different extents of mass transfer limitations and/or differences in fugacities of H-2, CO and water among the six catalysts could be ruled out as causes for the observed differences.
|
|
| 3. |
- Lögdberg, Sara, et al.
(author)
-
On the selectivity of cobalt-based Fischer-Tropsch catalysts : Evidence for a common precursor for methane and long-chain hydrocarbons
- 2010
-
In: Journal of Catalysis. - : Elsevier BV. - 0021-9517 .- 1090-2694. ; 274:1, s. 84-98
-
Journal article (peer-reviewed)abstract
- A total of 36 cobalt-based supported catalysts were investigated in the Fischer-Tropsch reaction at industrially relevant process conditions: 483 K, 20 bar, molar H-2/CO ratio = 2.1, pellet size: 53-90 mu m. The effect of adding water vapour to the feed was investigated for 20 of the catalysts, and a H-2/CO ratio of 1.0 was used for a few catalysts. The catalysts differed in support material, Co loading, promoters, Cl content, Co particle size (larger than similar to 6 nm), morphology, degree of reduction and preparation technique and showed a large variation in selectivity. For each set of process conditions, a linear relationship seems to exist between the selectivity to methane (and other light products) and C5+ indicating a common precursor, i.e. a common monomer pool, for all hydrocarbon products. A high selectivity to C5+ is mainly an effect of a high intrinsic chain-growth probability and unlikely to be a result of an enhanced cc-olefin readsorption. The universal effect of external water addition on the hydrocarbon selectivities is limited to a decrease in the methane selectivity. A small proportion of the catalysts developed "pure methanation" sites upon exposure to high partial pressures of water.
|
|
| 4. |
|
|
| 5. |
|
|
